Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Profit After Tax: 2020-2024

Historic Profit After Tax for Prime Medicine (PRME) over the last 5 years, with Dec 2024 value amounting to -$195.9 million.

  • Prime Medicine's Profit After Tax rose 3.69% to -$50.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$197.3 million, marking a year-over-year increase of 9.99%. This contributed to the annual value of -$195.9 million for FY2024, which is 1.14% up from last year.
  • According to the latest figures from FY2024, Prime Medicine's Profit After Tax is -$195.9 million, which was up 1.14% from -$198.1 million recorded in FY2023.
  • Over the past 5 years, Prime Medicine's Profit After Tax peaked at -$3.4 million during FY2020, and registered a low of -$198.1 million during FY2023.
  • Over the past 3 years, Prime Medicine's median Profit After Tax value was -$195.9 million (recorded in 2024), while the average stood at -$171.9 million.
  • Per our database at Business Quant, Prime Medicine's Profit After Tax plummeted by 4,749.47% in 2021 and then grew by 26.33% in 2022.
  • Yearly analysis of 5 years shows Prime Medicine's Profit After Tax stood at -$3.4 million in 2020, then slumped by 4,749.47% to -$165.4 million in 2021, then grew by 26.33% to -$121.8 million in 2022, then tumbled by 62.64% to -$198.1 million in 2023, then grew by 1.14% to -$195.9 million in 2024.